News

News-Medical.Net on MSN4d
Body image concerns drive interest in GLP-1 weight loss drugs, study finds
A new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...
Medscape5d
Drug-Drug Interactions With Glucagon-like Peptide-1 Receptor Agonists
Objective: To review drug interaction studies of glucagon-like peptide-1 receptor agonists (GLP-1RAs) and concurrent oral medications. Data Sources: PubMed was searched (to December 5, 2011 ...
Healthline6d
What Are GLP-1 Receptor Agonists and How Do They Treat Type 2 Diabetes?
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a group of drugs used to treat type 2 diabetes and sometimes obesity. GLP-1 RAs are very effective at lowering blood sugar levels.
BenefitsPRO9d
Eli Lilly’s new GLP-1 weight loss drug, in pill form, would be more affordable than Ozempic
Orforglipron, which could become the first GLP-1 pill — a much more convenient option — is a step closer to hitting the ...
Hosted on MSN8mon
Considering taking Wegovy to lose weight? Here are the risks and benefits—and how it differs from Ozempic
So how does Wegovy work ... Let's look at what the science says. Wegovy is a brand name for the medication semaglutide. Semaglutide is a glucagon-like peptide-1 receptor agonist (GLP-1RA).
Medical News Today21d
Does Zepbound give you energy?
Zepbound belongs to a class of drugs called dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor ... They can look for other factors that may be contributing ...